Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic: A Randomized Controlled Study

NCT04009772 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04009772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04009772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic: A Randomized Controlled Study
Lead sponsor
Assiut University
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 1, 2019
Completion date
March 1, 2020
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergency cesarean section, infection wound